EUVIMEDEUVIMED entdecken
Crossref

ATP6V0A2 ‐Related Cutis Laxa: Identification of a Recurrent Exon 16 Deletion With Founder Effect in Southeastern Türkiye and a Novel Frameshift Variant

Zeynep Esener iD, Murat Öztürk iD, Esra Habiloğlu iD, Aysel Tekmenuray-Ünal iD, Gül Ünsel-Bolat iD, Figen Eşmeli iD, Abdullah Sezer iD, Edanur Bulut iD, Hilmi Bolat iD

American Journal of Medical Genetics Part A · 2026-07 · 200 (7) · 1515-1527

DOI: 10.1002/ajmg.a.70102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 24.02.2026. Verfasst von Zeynep Esener und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Balikesir University, Balikesir, Türkiye. Hauptthemen laut MEDLINE: Founder Effect, Frameshift Mutation, Cutis Laxa, Proton-Translocating ATPases. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ATP6V0A2 ‐related cutis laxa is a rare autosomal recessive disorder characterized by connective tissue abnormalities, developmental delay, and neurological features. While multiple sequence variants have been reported, exon‐level deletions are rarely documented, and their clinical significance remains largely unknown. This study aims to present the clinical and molecular characteristics of a novel frameshift variant and recurrent exon 16 deletions in the ATP6V0A2 gene, to investigate a potential founder effect in southeastern Türkiye, and to contribute to the expanding genotype–phenotype correlation in ATP6V0A2 ‐related cutis laxa. Ten cases from six unrelated families were evaluated. Exome sequencing, clinical exome sequencing, long‐range polymerase chain reaction, gel electrophoresis, and haplotype analysis were performed. Variant interpretation followed ACMG and ClinGen guidelines. Clinical features were assessed through physical examination, developmental history, and neuroimaging. A novel homozygous frameshift variant (c.235del, p.Leu79Phefs*13) associated with severe neurological regression was identified in one case. Nine individuals carried a recurrent homozygous 380 bp deletion spanning exon 16 (c.1936‐147_2055+113del). In our study, neurological regression—a feature rarely reported in the literature—was noted in two older patients. Haplotype analysis revealed shared homozygous regions in three cases, suggesting a founder effect. This cohort represents the largest reported series of ATP6V0A2 ‐CL cases with exon 16 deletion to date. This study expands the genotypic and phenotypic spectrum of ATP6V0A2 ‐CL and underscores the importance of copy number variation detection in next‐generation sequencing‐based diagnostics. The identification of a recurrent exon 16 deletion and shared haplotypes provides evidence for a founder effect in southeastern Türkiye and supports the implementation of population‐specific screening for this variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Founder EffectFrameshift MutationCutis LaxaProton-Translocating ATPasesHumansFemaleExonsMaleChild, PreschoolHaplotypesGenetic Association StudiesSequence DeletionTurkeyPedigreeChildPhenotypeInfantExome Sequencing

Stichwörter der Autor:innen

ATP6V0A2cutis laxafounder effecthaplotype analysis

Substanzen

ATP6V0A2 protein, humanProton-Translocating ATPases

Autor:innen und Institutionen

  • Department of Medical Genetics, Faculty of Medicine, Balikesir University, Balikesir, Türkiye.
  • Department of Medical Genetics, Batman Training and Research Hospital Batman, Batman, Türkiye.
  • Department of Medical Genetics, Antalya Education and Research Hospital, Antalya, Türkiye.
  • Department of Child and Adolescent Psychiatry, Faculty of Medicine, Balıkesir University, Balikesir, Türkiye.
  • Department of Neurology, Faculty of Medicine, Balikesir University, Balikesir, Türkiye.
  • Department of Medical Genetics, Etlik City Hospital, Ankara, Türkiye.

ORCID-Profile: Zeynep Esener, Murat Öztürk, Esra Habiloğlu, Aysel Tekmenuray-Ünal, Gül Ünsel-Bolat, Figen Eşmeli, Abdullah Sezer, Edanur Bulut, Hilmi Bolat

Zitieren

APA

Esener, Z., Öztürk, M., Habiloğlu, E., Tekmenuray-Ünal, A., Ünsel-Bolat, G., Eşmeli, F., Sezer, A., Bulut, E., & Bolat, H. (2026). ATP6V0A2 ‐Related Cutis Laxa: Identification of a Recurrent Exon 16 Deletion With Founder Effect in Southeastern Türkiye and a Novel Frameshift Variant. American Journal of Medical Genetics Part A, 200(7), 1515-1527. https://doi.org/10.1002/ajmg.a.70102

Vancouver

Esener Z, Öztürk M, Habiloğlu E, Tekmenuray-Ünal A, Ünsel-Bolat G, Eşmeli F, et al. ATP6V0A2 ‐Related Cutis Laxa: Identification of a Recurrent Exon 16 Deletion With Founder Effect in Southeastern Türkiye and a Novel Frameshift Variant. American Journal of Medical Genetics Part A. 2026;200(7):1515-1527. doi:10.1002/ajmg.a.70102

BibTeX
@article{Esener2026,
  author = {Esener, Zeynep and Öztürk, Murat and Habiloğlu, Esra and Tekmenuray-Ünal, Aysel and Ünsel-Bolat, Gül and Eşmeli, Figen and Sezer, Abdullah and Bulut, Edanur and Bolat, Hilmi},
  title = {ATP6V0A2 ‐Related Cutis Laxa: Identification of a Recurrent Exon 16 Deletion With Founder Effect in Southeastern Türkiye and a Novel Frameshift Variant},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  volume = {200},
  number = {7},
  pages = {1515--1527},
  doi = {10.1002/ajmg.a.70102}
}
Kostenlos starten →